Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Reprogramming Transcriptional Responses through Functionally-Distinct Classes of Enhancers in Prostate Cancer Cells
PubMed Full text in PMC Similar studies Analyze with GEO2R
Reprogramming Transcriptional Responses through Functionally-Distinct Classes of Enhancers in Prostate Cancer Cells [ChIP-Seq, Gro-Seq]
PubMed Full text in PMC Similar studies SRA Run Selector
Reprogramming Transcriptional Responses through Functionally-Distinct Classes of Enhancers in Prostate Cancer Cells [gene expression]
FOXA2/AP-1 drives prostate cancer lineage plasticity
PubMed Full text in PMC Similar studies
FOXA2/AP-1 drives prostate cancer lineage plasticity [RNA-seq]
FOXA2/AP-1 drives prostate cancer lineage plasticity [PDX ChIP-seq]
FOXA2/AP-1 drives prostate cancer lineage plasticity [ChIP-seq]
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation [RNA-seq]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation [ChIP-seq]
Next Generation Sequencing Facilitates Quantitative Analysis of effect of knockdown of GATA2 on AR binding sites
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells
Target Gene Repression Based on Dismissal of Polymerase II from Estrogen Receptor Trans-bound Enhancers Is Associated With Clinical Outcome in Human Breast Cancer
Target Gene Repression Based on Dismissal of Polymerase II from Estrogen Receptor Trans-bound Enhancers Is Associated With Clinical Outcome in Human Breast Cancer [GRO-seq]
Target Gene Repression Based on Dismissal of Polymerase II from Estrogen Receptor Trans-bound Enhancers Is Associated With Clinical Outcome in Human Breast Cancer [ChIP-seq]
Tracing Enhancer Networks using Epigenetic Traits (TENET)
Expression data from LNCaP and abl cells
Epigenomic profiling of neuroendocrine prostate cancer and prostate adenocarcinoma xenografts
Role of DNA methylation in FOXA1 cell type-specific recruitment to chromatin
Androgen receptor-independent function of FoxA1 in prostate cancer metastasis
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on